Denali Therapeutics Inc. DNLI Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Denali Therapeutics Inc. (DNLI) reported comprehensive income (loss), net of tax, attributable to parent of -$129.81M in Q1 2026.
- How has Denali Therapeutics Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Denali Therapeutics Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 2.4% year-over-year, from -$132.95M to -$129.81M.
- What is the long-term trend for Denali Therapeutics Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Denali Therapeutics Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 15.1% compound annual growth rate (CAGR), from -$292.84M to -$513.88M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric captures the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as foreign currency translation adjustments and unrealized gains or losses on investments. It provides a more holistic view of a company's financial performance than net income alone by including items that bypass the traditional income statement. Investors use this to assess the broader economic impact of market and currency shifts on the company's total financial position.